Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant

(

A-WISH

)

ITN Protocol #:

ITN030ST

Branded Name:

A-WISH

ClinicalTrials.Gov ID:

NCT00135694

Treatment Protocol #:

Immunosuppression withdrawal

Therapeutic Area:

Transplantation

Current Status:

Complete

ITN Website Clinical Trial Recruiting Site Document Portal Location Study on ITN TrialShare

Summary:

A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients

Clinical Operations Manager

ITN Biologist

ITN Biostat

ITN Clinical Trial Physician

NIAID Project Manager

Rho Scientist

PPD Lead Monitor

Study Personnel:

Protocol Chair

Abraham Shaked, MD PhD abraham.shaked@uphs.upenn.edu

Work:

215-662-6723

Protocol Chair

Michele DesMarais mdesmarais@immunetolerance.org

Work:

415-420-4250

Protocol Chair

Kristina Harris, PhD kharris@immunetolerance.org

Work:

240-235-6154

Protocol Chair

Sai Kanaparthi skanaparthi@immunetolerance.org

Work:

(240)235-6101

Protocol Chair

Peter Sayre psayre@immunetolerance.org

Work:

415-353-4423

Protocol Chair

Allison Priore allison.girouard@nih.gov

Work:

240-627-3550

Protocol Chair

David Ikle, PhD David_Ikle@rhoworld.com

Work:

919-595-6378

Protocol Chair

Susan McCachren susan_mccachren@rhoworld.com

Work:

919-595-6391